IVD Quality Control Market Trends

IVD Quality Control Market Trends

• Advancements in diagnostic technologies are a significant driver of the market.
   
• For instance, PCR technology is widely used for infectious disease testing, cancer diagnostics, and genetic testing. As the sensitivity and complexity of these tests increase, quality control becomes essential to ensure accuracy, particularly when detecting low-abundance genetic material or pathogens.
   
• Molecular diagnostic technologies such as PCR (polymerase chain reaction) and next-generation sequencing (NGS) have revolutionized disease detection and genetic testing by enabling the identification of specific genetic mutations, pathogens, and biomarkers at the molecular level.
   
• Additionally, advancements in immunoassays, such as multiplex assays, allow for the simultaneous detection of multiple biomarkers from a single sample. This complexity requires higher levels of quality control to ensure the assays perform correctly across all analytes. Advanced immunoassay systems, in particular, demand a wide range of control materials, including multianalyte controls, to verify the accuracy of all detectable markers.
   
• As immunoassays become more complex, quality control products must be capable of validating the performance of assays across various biomarkers and concentrations, further driving the market growth for IVD quality controls.